Edesa Biotech (EDSA) Free Cash Flow (2017 - 2026)
Edesa Biotech (EDSA) free cash flow from Dec 31, 2017 to Mar 31, 2026. The TTM Edesa Biotech (EDSA) free cash flow is -$7.53M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Edesa Biotech (EDSA) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +31.41% |
| 3 Years TTM | -14.43% |
| 5 Years TTM | -10.63% |
| All Time TTM | +5.41% |
Annual Free Cash Flow change of Edesa Biotech (EDSA)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$2.02M | -72.40% |
| 2025 | -$7.32M | +49.69% |
| 2024 | -$4.89M | -26.36% |
| 2023 | -$6.64M | -45.97% |
| 2022 | -$12M | -10.10% |
| 2021 | -$14M | +173.95% |
| 2020 | -$4.99M | +2.67% |
| 2019 | -$4.86M | +273.85% |
| 2018 | -$1.30M | -74.00% |
| 2017 | -$5M | N/A |
Comparison Edesa Biotech (EDSA) five years free cash flow CAGR with competitors
Edesa Biotech (EDSA) five years free cash flow CAGR is -10.66%.